
Nutshell Therapeutics uses AI-guided computational modules and experimental biochemistry to discover small-molecule and allosteric therapeutics for challenging targets. The platform combines a proprietary AI algorithm with biophysics-informed modeling, laboratory screening, and experimental tools to analyze protein dynamics and identify subtype- or mutation-selective compounds. Nutshell focuses on targets considered undruggable or difficult for conventional approaches and advances programs into clinical-stage development. The company operates as a drug discovery platform serving pharmaceutical and biotechnology partners to accelerate molecule discovery and development.

Nutshell Therapeutics uses AI-guided computational modules and experimental biochemistry to discover small-molecule and allosteric therapeutics for challenging targets. The platform combines a proprietary AI algorithm with biophysics-informed modeling, laboratory screening, and experimental tools to analyze protein dynamics and identify subtype- or mutation-selective compounds. Nutshell focuses on targets considered undruggable or difficult for conventional approaches and advances programs into clinical-stage development. The company operates as a drug discovery platform serving pharmaceutical and biotechnology partners to accelerate molecule discovery and development.